SCHEMBL2348685

SCHEMBL2348685

CCCCC(CC)(CCCC)CCCCO

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.52
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.50
TSHR P16473 2/20 0.50
HSD17B10 Q99714 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
CES2 O00748 1/20 0.34
LPAR1 Q92633 1/20 0.34
LPAR3 Q9UBY5 1/20 0.34
FDPS P14324 8/20 0.32
GGPS1 O95749 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2347120 0.97 SMN1; SMN2 (0.55) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL2343696 0.95 SMN1; SMN2 (0.52) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL2341162 0.93 LMNA (0.62) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL2344883 0.93 LMNA (0.62) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL2346987 0.92 SMN1; SMN2 (0.55) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL6131164 0.91 SMN1; SMN2 (0.48) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL2343020 0.90 SMN1; SMN2 (0.58) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL14214460 0.90 LMNA (0.48) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
1,4-Butanediol SCHEMBL5909563 0.88 SMN1; SMN2 (0.50) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
SCHEMBL9310750 0.88 SMN1; SMN2 (0.50) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078724-B1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES ASAHI CHEMICAL IND (JP) 2016-11-30 EP disclosed
CN-102112482-B Method for producing alkyl tin alkoxide compound and method for producing carbonate ester using the same ASAHI KASEI CHEMICALS CORP. (JP) 2016-01-20 CN disclosed
CN-104151162-A Process for production of alkyl tin alkoxide compound, and process for production of carbonate ester using the compound ASAHI KASEI CHEMICALS CORP 2014-11-19 CN disclosed
EP-2226328-B1 PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND ASAHI KASEI CHEMICALS CORP (JP) 2012-12-26 EP disclosed
US-8168812-B2 Process for producing alkyl tin alkoxide compound and process for producing carbonic acid ester using said compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-05-01 US disclosed
US-8008518-B2 Process for producing dialkyl tin dialkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-08-30 US disclosed
CN-102112482-A Method for producing alkyl tin alkoxide compound and method for producing carbonate ester using the same ASAHI CHEMICAL CORP 2011-06-29 CN disclosed
US-20100292496-A1 Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed
EP-2226328-A1 PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND Asahi Kasei Chemicals Corporation (JP) 2010-09-08 EP disclosed
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-02-18 US disclosed
EP-2078724-A1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES Asahi Kasei Chemicals Corporation (JP) 2009-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES DEK, DDT, DERA SMN1; SMN2 4349/4885LMNA 4325/4885ALDH1A1 1422/4885
US-20100292496-A1 Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound OXSR1, AOC2, OXER1 SMN1; SMN2 2341/4885LMNA 3334/4885ALDH1A1 1746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.